Kidney disease
Kidney disease, various kidney diseases. The internal organs of the human body maintain a dynamic balance between the internal and external environments. If a variety of pathogenic factors from both inside and outside destroy the balance of the human body, leading to dysfunction of the internal organs and blood, and affecting the kidneys, kidney disease will occur.
-
Site of disease:
kidney
-
Infectious :
Not contagious
-
Frequent population:
Obese people, people with high blood pressure, tired people...
-
Related symptoms:
Edema
anuria
polyuria
urine protein
fatigue
-
Concurrent disease:
Related Drugs
Shenyanan Capsule
Manufacturer:
Xiuzheng Pharmaceutical Group Changchun High Technology Pharmaceutical Co., Ltd.
Coenzyme A
Indication: It is mainly used for leukopenia and idiopathic thrombocytopenic purpura. It can be used as an auxiliary treatment for fatty liver, acute and chronic hepatitis, coronary sclerosis, chronic arteritis, myocardial infarction, nephrotic syndrome and uremia caused by chronic renal dysfunction, neonatal hypoxia, diabetes and acidosis.
Manufacturer:
Ma'anshan Fengyuan Pharmaceutical Co., Ltd.
Coenzyme A
Indication: It is mainly used for leukopenia and idiopathic thrombocytopenic purpura. It can be used as an auxiliary treatment for fatty liver, acute and chronic hepatitis, coronary sclerosis, chronic arteritis, myocardial infarction, nephrotic syndrome and uremia caused by chronic renal dysfunction, neonatal hypoxia, diabetes and acidosis.
Manufacturer:
Wuzhi Weierkang Biochemical Pharmaceutical Co., Ltd.
Coenzyme A
Indication: It is mainly used for leukopenia and idiopathic thrombocytopenic purpura. It can be used as an auxiliary treatment for fatty liver, acute and chronic hepatitis, coronary sclerosis, chronic arteritis, myocardial infarction, nephrotic syndrome and uremia caused by chronic renal dysfunction, neonatal hypoxia, diabetes and acidosis.
Coenzyme A
Indication: It is mainly used for leukopenia and idiopathic thrombocytopenic purpura. It can be used as an auxiliary treatment for fatty liver, acute and chronic hepatitis, coronary sclerosis, chronic arteritis, myocardial infarction, nephrotic syndrome and uremia caused by chronic renal dysfunction, neonatal hypoxia, diabetes and acidosis.
Manufacturer:
Sinopharm Ronshyn Pharmaceutical Co., Ltd.
Furosemide for injection
Indication: 1. Edema diseases include congestive heart failure, cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons). This type of drug may still be effective, especially when other diuretics are ineffective. It can be used in combination with other drugs to treat acute pulmonary edema and acute cerebral edema. 2. It is generally not the first choice for primary treatment, but when thiazide drugs are ineffective, especially when accompanied by renal insufficiency or crisis, this type of drug is particularly suitable. 3. Acute renal failure is used for various reasons that lead to insufficient renal blood perfusion, such as dehydration, shock, poisoning, anesthesia accidents and circulatory insufficiency. Timely application while correcting insufficient blood volume can reduce the chance of acute tubular necrosis. 4. Kalemia and hypercalcemia.
Manufacturer:
Hainan Hualon Pharmaceutical Co., Ltd.